bf/NASDAQ:IONS_icon.jpeg

NASDAQ:IONS

Ionis Pharmaceuticals, Inc.

  • Stock

USD

Last Close

38.27

15/05 20:00

Market Cap

7.39B

Beta: 0.54

Volume Today

1.26M

Avg: 904.55K

PE Ratio

−17.34

PFCF: −15.39

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
7.08M
-
7.16M
1.19%
6.59M
7.92%
7.19M
9.09%
8.74M
21.43%
9.28M
6.26%
13.38M
44.16%
20.07M
50.01%
23.39M
16.51%
23.42M
0.15%
25.23M
7.73%
average payables
10.62M
-
14.50M
36.45%
23.17M
59.83%
24.74M
6.77%
23.00M
7.01%
26.77M
16.39%
22.36M
16.47%
16.63M
25.62%
14.55M
12.51%
14.91M
2.48%
21.97M
47.35%
average receivables
5.81M
-
7.50M
29.09%
7.63M
1.69%
59.70M
682.48%
85.50M
43.22%
37.86M
55.72%
37.88M
0.06%
69.50M
83.48%
69M
0.72%
44M
36.23%
61.89M
40.66%
book value per share
3.42
-
2.19
36.04%
1.68
23.43%
0.82
50.91%
2.67
224.06%
7.92
196.88%
10.51
32.65%
6.04
42.53%
5.47
9.34%
4.04
26.21%
2.70
33.15%
capex per share
-0.05
-
-0.09
94.44%
-0.10
4.01%
-0.10
2.86%
-0.31
220.23%
-0.13
56.30%
-0.26
94.27%
-0.29
13.45%
-0.13
56.83%
-0.14
11.62%
-0.20
38.06%
capex to depreciation
-0.55
-
-1.18
115.41%
-1.15
2.82%
-1.28
11.22%
-4.53
255.30%
-1.41
68.93%
-2.27
61.00%
-2.39
5.45%
-0.92
61.74%
-0.91
0.65%
-1.25
36.93%
capex to operating cash flow
-0.08
-
-1.77
1,992.06%
-0.56
68.52%
0.10
118.49%
-0.22
311.40%
-0.03
86.53%
-0.10
258.43%
-1.14
989.75%
-0.58
49.18%
0.07
112.60%
0.09
24.34%
capex to revenue
-0.04
-
-0.05
42.42%
-0.04
20.13%
-0.03
19.68%
-0.07
124.22%
-0.03
60.53%
-0.03
9.76%
-0.06
74.28%
-0.02
60.75%
-0.03
54.93%
-0.04
3.86%
cash per share
6.41
-
6.89
7.38%
6.72
2.51%
5.52
17.79%
15.45
179.82%
29.39
90.27%
30.83
4.89%
24.26
21.32%
23.83
1.76%
26.07
9.37%
16.28
37.54%
days of inventory on hand
15.93
-
9.50
40.39%
7.81
17.73%
7.94
1.61%
9.73
22.50%
1.72K
17,597.76%
1.66K
3.61%
668.10
59.73%
823.11
23.20%
574.43
30.21%
1.14K
97.76%
days payables outstanding
21.83
-
27.15
24.36%
32.11
18.27%
22.39
30.28%
24.25
8.29%
5.75K
23,606.56%
1.47K
74.49%
523.14
64.32%
395.00
24.49%
467.23
18.29%
1.04K
122.63%
days sales outstanding
27.51
-
6.65
75.82%
14.61
119.64%
113.77
678.72%
45.26
60.22%
7.77
82.84%
20.48
163.67%
38.05
85.83%
27.94
26.58%
16.17
42.13%
45.31
180.27%
debt to assets
0.18
-
0.40
116.73%
0.43
7.43%
0.55
29.32%
0.40
26.45%
0.22
46.07%
0.22
0.96%
0.44
97.99%
0.45
2.24%
0.53
19.72%
0.49
8.92%
debt to equity
0.41
-
1.47
258.93%
2.03
37.96%
5.04
148.89%
1.62
67.93%
0.56
65.64%
0.48
12.83%
1.24
155.40%
1.51
22.02%
2.36
56.48%
3.76
59.25%
dividend yield
0.02
-
earnings yield
-0.01
-
-0.01
61.05%
-0.01
121.93%
-0.01
25.68%
-0.00
93.60%
0.04
4,098.62%
0.03
9.16%
-0.06
277.47%
-0.01
89.05%
-0.05
645.73%
-0.05
0.33%
enterprise value
3.90B
-
6.91B
77.44%
7.03B
1.73%
5.62B
20.09%
5.75B
2.29%
5.64B
1.93%
6.67B
18.27%
6.75B
1.25%
3.34B
50.56%
4.72B
41.30%
8.30B
75.97%
enterprise value over ebitda
-75.41
-
-248.42
229.43%
-126.60
49.04%
-121.33
4.16%
273.92
325.76%
-91.58
133.44%
18.22
119.89%
-39.25
315.45%
-158.92
304.91%
-8.41
94.71%
-25.70
205.80%
ev to operating cash flow
61.36
-
1.10K
1,692.53%
332.90
69.73%
-50.13
115.06%
33.01
165.85%
9.35
71.67%
19.29
106.25%
188.08
875.27%
108.36
42.39%
-17.19
115.86%
-26.99
57.01%
ev to sales
26.45
-
32.28
22.03%
24.79
23.21%
16.21
34.60%
11.32
30.16%
9.40
16.98%
5.94
36.84%
9.26
55.97%
4.12
55.51%
8.03
94.98%
10.54
31.15%
free cash flow per share
0.53
-
-0.04
107.78%
0.08
291.29%
-1.02
1,405.24%
1.10
207.50%
4.42
302.45%
2.21
50.03%
-0.04
101.67%
0.09
347.66%
-2.08
2,369.75%
-2.34
12.87%
free cash flow yield
0.01
-
-0.00
105.02%
0.00
290.70%
-0.02
1,790.01%
0.02
202.22%
0.08
274.46%
0.04
55.28%
-0.00
101.79%
0.00
560.15%
-0.05
1,928.66%
-0.05
15.73%
graham net net
2.28
-
1.01
55.83%
0.51
49.81%
-0.50
198.77%
8.59
1,816.42%
18.31
113.25%
20.18
10.20%
13.66
32.27%
11.20
18.02%
12.46
11.20%
-1.29
110.35%
graham number
6.50
-
4.04
37.87%
5.28
30.56%
3.64
30.97%
1.70
53.31%
19.20
1,029.54%
22.28
16.04%
21.77
2.30%
5.03
76.88%
13.15
161.34%
12.47
5.21%
income quality
-1.05
-
-0.16
84.60%
-0.24
48.43%
1.30
641.23%
-10.07
877.41%
2.80
127.85%
1.14
59.35%
-0.07
106.47%
-1.08
1,360.62%
1.02
194.45%
0.84
17.47%
intangibles to total assets
0.02
-
0.02
12.31%
0.02
2.85%
0.02
10.47%
0.02
25.42%
0.01
45.88%
0.01
11.84%
0.01
47.20%
0.01
5.00%
0
100%
0
interest coverage
-2.67
-
-2.15
19.49%
-2.06
4.03%
-1.19
42.12%
0.55
145.92%
-1.37
349.94%
7.47
645.11%
-3.82
151.18%
-6.98
82.49%
-50.60
625.31%
-4.68
90.75%
interest debt per share
1.58
-
3.40
116.04%
3.70
8.80%
4.47
20.72%
4.67
4.53%
4.74
1.37%
5.44
14.76%
7.79
43.25%
8.29
6.44%
9.59
15.73%
10.68
11.33%
inventory turnover
22.91
-
38.43
67.76%
46.72
21.55%
45.98
1.58%
37.53
18.37%
0.21
99.43%
0.22
3.75%
0.55
148.30%
0.44
18.83%
0.64
43.29%
0.32
49.43%
invested capital
0.41
-
1.47
258.93%
2.03
37.96%
5.04
148.89%
1.62
67.93%
0.56
65.64%
0.48
12.83%
1.24
155.40%
1.51
22.02%
2.36
56.48%
3.76
59.25%
market cap
4.40B
-
7.27B
65.05%
7.41B
2.04%
5.78B
21.98%
6.24B
7.85%
7.15B
14.67%
8.46B
18.23%
7.89B
6.66%
4.29B
45.64%
5.36B
24.85%
7.24B
35.21%
net current asset value
266.74M
-
138.57M
48.05%
81.69M
41.05%
-14.97M
118.33%
264.68M
1,868.06%
727.26M
174.77%
1.17B
61.29%
583M
50.30%
505M
13.38%
242M
52.08%
38.47M
84.10%
net debt to ebitda
9.80
-
12.70
29.54%
6.87
45.90%
3.55
48.27%
-23.33
756.52%
24.63
205.56%
-4.89
119.86%
6.65
235.88%
45.43
583.61%
1.14
97.48%
-3.27
385.36%
net income per share
-0.55
-
-0.33
39.64%
-0.74
122.61%
-0.72
2.93%
-0.05
93.27%
2.07
4,397.52%
2.10
1.51%
-3.49
266.10%
-0.21
94.10%
-1.90
825.61%
-2.56
34.39%
operating cash flow per share
0.57
-
0.05
90.71%
0.18
230.42%
-0.93
625.35%
1.40
251.48%
4.56
224.47%
2.47
45.80%
0.26
89.59%
0.22
15.05%
-1.93
985.65%
-2.15
11.03%
payables turnover
16.72
-
13.44
19.59%
11.37
15.45%
16.30
43.43%
15.05
7.66%
0.06
99.58%
0.25
292.04%
0.70
180.25%
0.92
32.44%
0.78
15.46%
0.35
55.08%
receivables turnover
13.27
-
54.87
313.60%
24.98
54.47%
3.21
87.16%
8.06
151.36%
47.00
482.84%
17.83
62.07%
9.59
46.19%
13.06
36.20%
22.58
72.81%
8.06
64.32%
research and ddevelopement to revenue
1.25
-
1.13
9.66%
1.14
0.64%
0.99
12.56%
0.74
25.71%
0.69
6.31%
0.41
39.98%
0.73
76.86%
0.79
8.17%
1.42
78.76%
1.14
19.51%
return on tangible assets
-0.07
-
-0.04
43.19%
-0.09
126.24%
-0.10
2.96%
-0.00
95.27%
0.10
2,354.73%
0.09
11.47%
-0.21
324.92%
-0.01
94.55%
-0.11
849.04%
-0.12
14.97%
revenue per share
1.33
-
1.82
36.52%
2.37
30.23%
2.87
20.95%
4.09
42.82%
4.53
10.71%
8.02
77.00%
5.22
34.91%
5.74
10.00%
4.14
27.95%
5.50
32.92%
roe
-0.16
-
-0.15
5.64%
-0.44
190.72%
-0.87
97.73%
-0.02
97.92%
0.26
1,547.54%
0.20
23.48%
-0.58
389.05%
-0.04
93.50%
-0.47
1,154.38%
-0.95
101.03%
roic
-0.08
-
-0.05
37.95%
-0.11
131.66%
-0.07
36.44%
0.02
129.16%
0.11
410.67%
0.15
37.18%
-0.02
113.40%
-0.01
24.16%
-0.20
1,284.00%
-0.19
5.65%
sales general and administrative to revenue
0.10
-
0.09
7.15%
0.13
39.33%
0.14
7.04%
0.21
52.36%
0.41
90.89%
0.26
37.35%
0.49
90.01%
0.21
56.55%
0.26
21.36%
0.30
15.33%
shareholders equity per share
3.42
-
2.19
36.04%
1.68
23.43%
0.82
50.91%
2.67
224.06%
7.92
196.88%
10.51
32.65%
6.04
42.53%
5.47
9.34%
4.04
26.21%
2.70
33.15%
stock based compensation to revenue
0.08
-
0.15
89.03%
0.21
42.67%
0.21
0.50%
0.17
18.59%
0.22
29.30%
0.13
40.39%
0.32
141.85%
0.15
52.80%
0.17
14.65%
0.13
21.35%
tangible asset value
358.30M
-
237.90M
33.60%
181.47M
23.72%
79.20M
56.36%
396.71M
400.90%
1.16B
193.19%
1.66B
42.66%
815.06M
50.88%
743.00M
8.84%
573M
22.88%
386.69M
32.52%
tangible book value per share
3.24
-
2.02
37.66%
1.52
25.01%
0.65
56.80%
3.20
388.45%
8.79
174.79%
11.85
34.84%
5.84
50.74%
5.27
9.75%
4.04
23.33%
2.70
33.15%
working capital
637.70M
-
721.26M
13.10%
688.13M
4.59%
664.15M
3.48%
943.24M
42.02%
1.93B
104.36%
2.45B
27.00%
1.84B
24.84%
2.10B
14.35%
1.89B
10.12%
2.19B
16.01%

All numbers in USD (except ratios and percentages)